Tech Company Financing Transactions
Moncyte Health Funding Round
On 10/8/2024, Moncyte Health announced $1.1 million in Seed financing from Inventure and Business Finland.
Transaction Overview
Company Name
Announced On
10/8/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$1,100,000
Round
Seed
Investors
Inventure (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further enhance its go-to-market strategy and development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Haartmaninkatu 4
Helsinki, 00290
Finland
Helsinki, 00290
Finland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Atherosclerosis is characterized by the accumulation of fatty deposits containing cholesterol in artery walls. These fat deposits are called plaques. Plaques can grow, destabilize and rupture, resulting in an obstruction of the blood flow through the artery. If this happens in an artery supporting the heart it leads to a heart attack, if the artery supports the brain it results in a stroke.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tamara Alagirova
Chief Scientific Officer
Simon Pfisterer
Browse more venture capital transactions:
Prev: 10/8/2024: Loot Labs venture capital transaction
Next: 10/8/2024: Synergi venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs